# Maternal KIR and Fetal HLA Influence Reproductive Success in ART-oocyte Donor.

> **NCT05606679** · — · UNKNOWN · sponsor: **IVI Madrid** · enrollment: 400 (estimated)

## Conditions studied

- Reproductive Issues

## Interventions

- **GENETIC:** Analysis combinations of maternal KIR and HLA-C genotypes

## Key facts

- **NCT ID:** NCT05606679
- **Lead sponsor:** IVI Madrid
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05606679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05606679, "Maternal KIR and Fetal HLA Influence Reproductive Success in ART-oocyte Donor.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05606679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*